{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Melbourne",
      "address_1": "1515 Elizabeth St Ste J",
      "reason_for_recall": "Lack of assurance of sterility.",
      "address_2": "",
      "product_quantity": "",
      "code_info": "All lots remaining within expiry.",
      "center_classification_date": "20190910",
      "distribution_pattern": "Continental U.S. and Puerto Rico",
      "state": "FL",
      "product_description": "Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901",
      "report_date": "20190918",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Pacifico National, Inc. dba AmEx Pharmacy",
      "recall_number": "D-1849-2019",
      "initial_firm_notification": "Press Release",
      "product_type": "Drugs",
      "event_id": "83702",
      "termination_date": "20201008",
      "more_code_info": "",
      "recall_initiation_date": "20190830",
      "postal_code": "32901-3000",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}